Search research articles
Contact Us
Filters
Showing results (101-110 of 110) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 110 results.
The Journal of Pharmacology and Experimental Therapeutics
|
July 22, 2016
Unexpected Potency Differences between B-Cell-Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound
Amy M Nicoletti, Cynthia Hess Kenny, Ashraf M Khalil, et al.
Journal of Lipid Research
|
November 21, 2022
Dalcetrapib and anacetrapib increase apolipoprotein E-containing HDL in rabbits and humans
Mathieu R Brodeur, David Rhainds, Daniel Charpentier, et al.
Blood
|
October 16, 2025
Ramantamig (JNJ-79635322), a novel T-cell-engaging trispecific antibody targeting BCMA, GPRC5D, and CD3, in multiple myeloma models
Kodandaram Pillarisetti, Danlin Yang, Leopoldo Luistro, et al.
Atherosclerosis
|
August 11, 2014
The interleukin-1β modulator gevokizumab reduces neointimal proliferation and improves reendothelialization in a rat carotid denudation model
François Roubille, David Busseuil, Yanfen Shi, et al.
International Journal of Cardiology
|
April 30, 2016
HDL mimetic peptide CER-522 treatment regresses left ventricular diastolic dysfunction in cholesterol-fed rabbits
Nolwenn Merlet, David Busseuil, Teodora Mihalache-Avram, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 17, 2013
Evaluation of links between high-density lipoprotein genetics, functionality, and aortic valve stenosis risk in humans
Benoit J Arsenault, Marie-Pierre Dubé, Mathieu R Brodeur, et al.
Circulation. Genomic and Precision Medicine
|
April 2, 2021
Role of Adenylate Cyclase 9 in the Pharmacogenomic Response to Dalcetrapib: Clinical Paradigm and Molecular Mechanisms in Precision Cardiovascular Medicine
David Rhainds, Chris J Packard, Mathieu R Brodeur, et al.
The Journal of Clinical Investigation
|
June 5, 2002
Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations
Jordan S Orange, Scott R Brodeur, Ashish Jain, et al.
Immunity
|
May 12, 2019
T-bet Transcription Factor Promotes Antibody-Secreting Cell Differentiation by Limiting the Inflammatory Effects of IFN-γ on B Cells
Sara L Stone, Jessica N Peel, Christopher D Scharer, et al.
Circulation
|
April 21, 2018
ADCY9 (Adenylate Cyclase Type 9) Inactivation Protects From Atherosclerosis Only in the Absence of CETP (Cholesteryl Ester Transfer Protein)
Yohann Rautureau, Vanessa Deschambault, Marie-Ève Higgins, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 110) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 110 results.
The Journal of Pharmacology and Experimental Therapeutics
|
July 22, 2016
Unexpected Potency Differences between B-Cell-Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound
Amy M Nicoletti, Cynthia Hess Kenny, Ashraf M Khalil, et al.
Journal of Lipid Research
|
November 21, 2022
Dalcetrapib and anacetrapib increase apolipoprotein E-containing HDL in rabbits and humans
Mathieu R Brodeur, David Rhainds, Daniel Charpentier, et al.
Blood
|
October 16, 2025
Ramantamig (JNJ-79635322), a novel T-cell-engaging trispecific antibody targeting BCMA, GPRC5D, and CD3, in multiple myeloma models
Kodandaram Pillarisetti, Danlin Yang, Leopoldo Luistro, et al.
Atherosclerosis
|
August 11, 2014
The interleukin-1β modulator gevokizumab reduces neointimal proliferation and improves reendothelialization in a rat carotid denudation model
François Roubille, David Busseuil, Yanfen Shi, et al.
International Journal of Cardiology
|
April 30, 2016
HDL mimetic peptide CER-522 treatment regresses left ventricular diastolic dysfunction in cholesterol-fed rabbits
Nolwenn Merlet, David Busseuil, Teodora Mihalache-Avram, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 17, 2013
Evaluation of links between high-density lipoprotein genetics, functionality, and aortic valve stenosis risk in humans
Benoit J Arsenault, Marie-Pierre Dubé, Mathieu R Brodeur, et al.
Circulation. Genomic and Precision Medicine
|
April 2, 2021
Role of Adenylate Cyclase 9 in the Pharmacogenomic Response to Dalcetrapib: Clinical Paradigm and Molecular Mechanisms in Precision Cardiovascular Medicine
David Rhainds, Chris J Packard, Mathieu R Brodeur, et al.
The Journal of Clinical Investigation
|
June 5, 2002
Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations
Jordan S Orange, Scott R Brodeur, Ashish Jain, et al.
Immunity
|
May 12, 2019
T-bet Transcription Factor Promotes Antibody-Secreting Cell Differentiation by Limiting the Inflammatory Effects of IFN-γ on B Cells
Sara L Stone, Jessica N Peel, Christopher D Scharer, et al.
Circulation
|
April 21, 2018
ADCY9 (Adenylate Cyclase Type 9) Inactivation Protects From Atherosclerosis Only in the Absence of CETP (Cholesteryl Ester Transfer Protein)
Yohann Rautureau, Vanessa Deschambault, Marie-Ève Higgins, et al.
Page
of 11